期刊文献+

Duchenne型肌营养不良治疗的研究进展 被引量:7

下载PDF
导出
摘要 自从法国医学家Guillaume-Benjamin-Amand Duchenne于1861年首次详细描述Duchenne型肌营养不良(DMD)以来,不少临床医学家和遗传学家对该病进行了系统而深入的研究,虽然已在诊断和遗传咨询方面取得了重大进展,但在治疗上却停滞不前.仍然无法阻止患者进行性加重的肌萎缩和在20岁左右死亡的命运。这是一种既令人感兴趣又使人悲伤的疾病.感兴趣的是其特殊的临床特征和神秘的疾病本质,悲伤的是虽然进行了艰苦的努力但仍无法阻止病情的进展,肌萎缩随着儿童的发育而逐渐进展,随着年龄的增长而加重,在青春期或青年期无一例外地走向生命的终点。
作者 张成
出处 《中国现代神经疾病杂志》 CAS 2007年第2期120-125,共6页 Chinese Journal of Contemporary Neurology and Neurosurgery
  • 相关文献

参考文献30

  • 1[1]Monaco AP,Bertelson CJ,Liechti-Gallati S,et al.An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus.Genomics,1988,2:90-95.
  • 2[2]Wilton SD,Lloyd F,Carville K,et al.Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotide.Neuromuscul Disord,1999,9:330-338.
  • 3[3]van Deutekom JC,Bremmer-Bout M,Janson AA,et al.Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.Hum Mol Genet,2001,10:1547-1554.
  • 4[4]Aartsma-Rus A,Janson AA,Kaman WE,et al.Therapeutic antisense-induced exon skipping in cultured muscle cells from six different DMD patients.Hum Mol Genet,2003,12:907-914.
  • 5[5]Takeshima Y,Yagi M,Wada H,et al.Intravenous infusion of an antisense oligonucleotide results in exon skipping in muscle dystrophin mRNA of Duchenne muscular dystrophy.Pediatr Res,2006,59:690-694.
  • 6[6]Watchko J,O'Day T,Wang B,et al.Adeno-associated virus vectormediated minidystrophin gene therapy improves dystrophic muscle contractile function in mdx mice.Hum Gene Ther,2002,13:1451-1460.
  • 7[7]Kimura S,Ito K,Miyagi T,et al.A novel approach to identify Duchenne muscular dystrophy patients for aminoglycoside antibiotics therapy.Brain Dev,2005,27:400-405.
  • 8[8]Barton-Davis ER,Cordier L,Shoturma DL,et al.Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice.J Clin Invest,1999,104:375-381.
  • 9[9]Hamed SA.Drug evaluation:PTC-124:a potential treatment of cystic fibrosis and Duchenne muscular dystrophy.IDrugs,2006,9:783-789.
  • 10[10]Wagner KR,Hamed S,Hadley DW,et al.Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.Ann Neurol,2001,49:706-711.

二级参考文献10

  • 1Minguell JJ, Erices A, Conget P. Mesenchymal stem cells.Exp Biol Med, 2001, 226:507-520.
  • 2Gussoni E, Soneoka Y, Strikland CD, et al. Dystrophin expression in the mdx mice restored by stem cell transplantation. Nature, 1999, 401(6751):390-394.
  • 3Khurana TS, Watkins SC, Chafey P, et al. Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord, 1991, 1,185-194.
  • 4Anne ED, Jill AR, Judith AS, et al. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell, 1997, 90:717-727.
  • 5Deconinck N, Rafael JA, Beckers-Bleukx G, et al.Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.Neuromuseul Disord, 1998, 8(6):362-370.
  • 6Turner PR, Westwood T,Regen CM, et al. Increased protein degradation results from elevated free calcium levers found in muscle from mdx mice. Nature, 1998, 335:735-738.
  • 7Cai B, Spencer MJ, Nakamum G, et al. Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol, 2000, 156(5): 1789-1796.
  • 8Partridge T. The ‘Fantastic Voyage’ of muscle progenitor cells. Nat Med, 1998, 4(5):554.
  • 9张为西,张成,刘焯霖,王训,刘晓蓉.建立Duchenne型肌营养不良鼠的骨髓移植模型[J].中山医科大学学报,2001,22(2):89-92. 被引量:13
  • 10陈松林,张成,刘晓蓉,张为西,卢锡林,黄文.Utrophin+/-mdx鼠子代的基因型鉴定[J].中山医科大学学报,2003,24(1). 被引量:2

共引文献7

同被引文献128

  • 1陈浩刚,王慕璇,韩智玲,.70例假肥大型肌营养不良患者的心电图Q波改变[J].现代医学仪器与应用,2008,0(3):16-17. 被引量:4
  • 2申本昌,张成,陈松林,孙筱放,李少英,姚晓黎,王淑辉,卢锡林.非缺失/重复型Duchenne肌营养不良症患者的致病点突变分析[J].中华医学遗传学杂志,2006,23(4):392-396. 被引量:16
  • 3白芹,陈日新,白旭.肌营养不良症肌电图诊断的研究[J].江西医药,2007,42(4):343-345. 被引量:3
  • 4麻宏伟.Duchenne型肌营养不良症的诊断与治疗[J].中国实用儿科杂志,2007,22(7):552-554. 被引量:20
  • 5胡亚美 江载芳.诸福棠实用儿科学[M]:7版[M].北京:人民卫生出版社,2002.1294.
  • 6刘焯霖,梁秀龄.张成.神经遗传病学3版.北京:人民卫生出版社,2012:194-285.
  • 7Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord, 1991,1:19-29.
  • 8Mendell JR, Shilling C, Leslie ND, Flanigan KM, al-Dahhak R, Gastier - Foster J, Kneile K, Dunn DM, Duval B, Aoyagi A, Hamil C, Mahmoud M, Roush K, Bird L, Rankin C, Lilly H, Street N, Chandrasekar H, Weiss RB. Evidence-based path to newborn screening for Duchenne muscular dystrophy. Ann Neurol, 2012, 71:304-313.
  • 9Dooley J, Gordon KE, Dodds L, MacSween J. Duchenne muscular dystrophy: a 30 · year population · based incidence study. Clin Pediatr (Phila), 2010, 49:177-179.
  • 10Landfeldt E, Lindgren P, Bell CF, Schmitt C, Guglieri M, Straub V, Lochmiiller H, Bushby K. The burden of Duchenne muscular dystrophy: an international, cross - sectional study. Neurology, 2014,83:529-536.

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部